Connection

Deepak Govil to Immunologic Factors

Back to Details
This is a "connection" page, showing publications Deepak Govil has written about Immunologic Factors.
Deepak Govil
Connection Strength
0.017
Immunologic Factors
  1. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med. 2021 05; 9(5):511-521.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.